Should You be Optimistic on the Growth Prospects of CryoPort (CYRX)?

Should You be Optimistic on the Growth Prospects of CryoPort (CYRX)?

Conestoga Capital Advisors' Q2 2024 investor letter discusses market moderation. Their Micro-Cap Strategy declined 8.52%, with underperformance in sectors like Telecommunications and Health Care. Cryoport, Inc.

Read More

Did you find this insightful?